Compare ROKU & HOLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ROKU | HOLX |
|---|---|---|
| Founded | 2002 | 1985 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Cable & Other Pay Television Services | Medical Electronics |
| Sector | Telecommunications | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 15.9B | 16.6B |
| IPO Year | 2017 | 1990 |
| Metric | ROKU | HOLX |
|---|---|---|
| Price | $109.35 | $75.15 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 19 | 15 |
| Target Price | ★ $115.05 | $79.64 |
| AVG Volume (30 Days) | 2.9M | ★ 2.9M |
| Earning Date | 10-30-2025 | 02-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 2.49 |
| Revenue | ★ $4,543,395,000.00 | $4,100,500,000.00 |
| Revenue This Year | $16.44 | $6.69 |
| Revenue Next Year | $13.05 | $5.74 |
| P/E Ratio | ★ N/A | $30.12 |
| Revenue Growth | ★ 16.61 | 1.74 |
| 52 Week Low | $52.43 | $51.90 |
| 52 Week High | $116.66 | $76.29 |
| Indicator | ROKU | HOLX |
|---|---|---|
| Relative Strength Index (RSI) | 67.15 | 70.32 |
| Support Level | $91.66 | $74.77 |
| Resistance Level | $112.42 | $75.05 |
| Average True Range (ATR) | 4.04 | 0.28 |
| MACD | 1.54 | -0.12 |
| Stochastic Oscillator | 85.87 | 77.85 |
Roku enables consumers to stream television programming. It has more than 90 million streaming households and provided 127 billion streaming hours in 2024. Roku is the top streaming operating system in the US, reaching more than half of broadband households, according to the company. Roku's OS is built into streaming devices and televisions that Roku sells and on connected televisions from other manufacturers that license Roku's name and software. Roku also operates the Roku Channel, a free, ad-supported streaming television platform that offers a mix of on-demand and live television programming. Roku generates revenue primarily from selling devices, licensing, and advertising, and it receives fees from subscription streaming platforms that sell subscriptions through Roku.
Hologic manufactures proprietary products for the healthcare needs of women. The company operates in four segments: diagnostics (44% of total sales), breast health (38%), surgical (16%), and skeletal health (2%). While the company traditionally focused on breast health, the acquisition of Gen-Probe put greater emphasis on commercial diagnostics. The United States accounts for the largest portion of the firm's revenue (69%), followed by Europe (20%), Asia (8%), and other international markets (3%). Hologic is headquartered in Bedford, Massachusetts.